Back to Authors

Ohtsu, Atsushi

https://orcid.org/0000-0003-1329-0628

A5024904484 | I4210087348

Mayo Clinic

National Cancer Centre Japan

Citations 3

Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2).

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS3655-TPS3655

10.1200/jco.2014.32.15_suppl.tps3655

Association of chemotherapy induced neutropenia at 1-month mark (CIN-1-month) and overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort study.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15124-e15124

10.1200/jco.2016.34.15_suppl.e15124

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

JAMA Oncology | March 15, 2018 | Volume: 4 | Issue: 5 | Pages: e180013

10.1001/jamaoncol.2018.0013 | PMID 29543932